Lois E. Shepherd

Queen's University

Papers

1

Total Citations

26

H-Index

1

About

Dr. Lois E. Shepherd is a leading figure in gynecologic oncology, renowned for her transformative work in refining surgical treatments for early-stage cervical cancer. Her research focuses on de-escalating radical surgery to reduce patient morbidity without compromising oncologic outcomes. Dr. Shepherd’s most impactful contribution is her leadership of the landmark international phase III SHAPE trial (CCTG CX.5), which compared radical hysterectomy to simple hysterectomy in patients with low-risk early-stage cervical cancer. This practice-changing study, published in 2023, demonstrated that less radical surgery is safe and associated with significantly less morbidity, challenging decades of standard care. With over 26 citations already, the SHAPE trial has rapidly become a cornerstone reference in the field. Dr. Shepherd’s work exemplifies how rigorous, collaborative clinical research—conducted through the Gynecologic Cancer Intergroup and Canadian Cancer Trials Group—can directly improve patients’ quality of life. Her contributions have earned her international recognition as a pioneer in surgical de-escalation, guiding a new generation of clinicians toward more personalized, less invasive treatments for cervical cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
26
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
An international randomized phase III trial comparing radical hysterectomy and pelvic node dissection (RH) vs simple hysterectomy and pelvic node dissection (SH) in patients with low-risk early-stage cervical cancer (LRESCC): A Gynecologic Cancer Intergroup study led by the Canadian Cancer Trials Group (CCTG CX.5-SHAPE).
26 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Queen's University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago